STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. BTAI
  4. [ARS] BioXcel Therapeutics, Inc. SEC Filing

[ARS] BioXcel Therapeutics, Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - BioXcel Therapeutics, Inc.

ARS Filing - BioXcel Therapeutics, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: BioXcel Therapeutics, Inc. (BTAI)

Acceptance Date: 2025-11-12T17:05:00.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock BTAI logo
Bioxcel Therapeutics Inc

NASDAQ:BTAI

BTAI Rankings

#5734 Ranked by Market Cap
N/A Ranked by Dividends

BTAI Latest News

Nov 12, 2025
BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease
Oct 14, 2025
BioXcel Therapeutics Announces Positive Results from Correlation Study Supporting SERENITY At-Home Exploratory Efficacy Outcomes
Oct 13, 2025
BioXcel Therapeutics to Ring Nasdaq Closing Bell on October 14 to Celebrate a Transformative Milestone in Neuroscience Innovation
Sep 18, 2025
BioXcel Therapeutics Regains Compliance with Nasdaq Market Value of Listed Securities Requirements
Sep 10, 2025
BioXcel Therapeutics Reports Positive Topline Exploratory Efficacy Data from SERENITY At-Home Pivotal Phase 3 Safety Trial for Agitation Associated with Bipolar Disorders or Schizophrenia

BTAI Latest SEC Filings

Nov 12, 2025
[DEF 14A] BioXcel Therapeutics, Inc. Definitive Proxy Statement
Nov 12, 2025
[10-Q] BioXcel Therapeutics, Inc. Quarterly Earnings Report
Nov 12, 2025
[8-K] BioXcel Therapeutics, Inc. Reports Material Event
Nov 10, 2025
[8-K] BioXcel Therapeutics, Inc. Reports Material Event
Nov 3, 2025
[Form 4] BioXcel Therapeutics, Inc. Insider Trading Activity

BTAI Stock Data

32.02M
20.94M
3.8%
6.23%
25.27%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW HAVEN